Target intelligence / Profile preview

Corynebacterium diphtheriae

Molecular classification
Bacterium, Gram-positive bacillus, Actinobacteria
01

Overview

Corynebacterium diphtheriae is a Gram-positive, non-motile, non-capsulated, club-shaped bacillus responsible for diphtheria, a serious infectious disease that primarily affects the mucous membranes of the respiratory tract or skin. Its pathogenicity is largely due to a potent exotoxin (diphtheria toxin) encoded by a bacteriophage-borne gene (tox). Toxigenic strains colonize the upper respiratory tract or skin, forming a pseudomembrane and releasing toxin systemically, which can lead to severe complications including myocarditis and neuropathy. Laboratory diagnosis relies on culture, toxin detection, and PCR-based identification. Infection is prevented with vaccination (diphtheria toxoid), and treated with antitoxin and antibiotics such as penicillin or erythromycin. Drug-resistant strains have emerged, highlighting ongoing challenges in management[1][3][4][5].

Other names
Klebs–Löffler bacillusKlebs-Loeffler bacillus
02

Mechanism of action

For antitoxin, neutralization of diphtheria toxin; for antibiotics, inhibition of bacterial cell wall synthesis (penicillin), inhibition of protein synthesis (erythromycin)[4]

03

Biological functions

InfectionPathogenesisToxin production
04

Disease associations

Infection, specifically diphtheria
05

Safety considerations

Emergence of antibiotic-resistant strainstoxin-mediated cardiac and neurological complicationsrisk during outbreaks, especially in unvaccinated populations[4]
06

Interacting drugs

Penicillin

3 more in the full profile.

07

Biomarkers

Diphtheria toxin (tox gene presence)culture on selective mediadetection of characteristic pseudomembrane in clinical diagnosis

Beyond the preview

Go deeper on Corynebacterium diphtheriae.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Corynebacterium diphtheriae.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call